Organigram (NASDAQ:OGI - Get Free Report) posted its quarterly earnings data on Monday. The company reported ($0.13) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.03) by ($0.10), Zacks reports. Organigram had a negative return on equity of 8.59% and a negative net margin of 31.69%. The company had revenue of $45.58 million for the quarter, compared to the consensus estimate of $61.27 million.
Organigram Stock Up 9.7%
Shares of NASDAQ OGI traded up $0.12 during mid-day trading on Friday, reaching $1.36. 1,373,683 shares of the company were exchanged, compared to its average volume of 675,719. Organigram has a 52 week low of $0.85 and a 52 week high of $2.11. The stock has a market capitalization of $182.02 million, a PE ratio of -3.58 and a beta of 1.35. The company's 50 day moving average price is $1.07 and its 200 day moving average price is $1.35.
Organigram Company Profile
(
Get Free Report)
Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.
Read More
Before you consider Organigram, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Organigram wasn't on the list.
While Organigram currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
